Cytokinetics (CYTK) P/E ratio

P/E ratio · fiscal 2016
31.2×

Only 2 fiscal years of P/E ratio are on record here for Cytokinetics (CYTK); a history needs at least 3. Figures as of 18 Nov 2026, 11:33 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio, fiscal 2016
31.2×
Fiscal years on record
22009–2016

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Not enough data

A history of P/E ratio needs at least 3 fiscal years; 2 are on record here for Cytokinetics. Nothing is estimated to fill the gap. What is on record is in the table below.

Cytokinetics P/E ratio, year by year

Cytokinetics (CYTK) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
2025——$63.54-$6.54
2024——$47.04-$5.26
2023——$83.49-$5.45
2022——$45.82-$4.33
2021——$45.58-$2.80
2020——$20.78-$1.97
2019——$10.61—
2018——$6.32—
2017——$8.15-$2.59
201631.2×—$12.15$0.39
2015——$10.46-$0.97
2014——$8.01-$0.41
2013——$6.50—
2012——$3.96—
2011——$5.76-$4.32
2010——$12.54-$4.62
20096.9×—$17.46$2.52
2008——$17.10—
2007——$28.38—
2006——$44.88—
2005——$39.12—
2004——$61.50—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

More on CYTK

Cytokinetics, figure by figure

Cytokinetics (CYTK) overview: price, valuation and scorecardAll health care companies by market value

Cytokinetics P/E ratio: questions and answers

How is Cytokinetics's P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E. For Cytokinetics it is on record here for 2 fiscal years, 2009 to 2016.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Cytokinetics (CYTK) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/CYTK/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.